Sysmex (OTCMKTS:SSMXY) Shares Gap Down – Here’s Why

Shares of Sysmex Corporation ADR (OTCMKTS:SSMXY) gapped down before the market opened on Tuesday . The stock had previously closed at $9.93, but opened at $9.33. Sysmex shares last traded at $9.64, with a volume of 2,979 shares.

Sysmex Stock Performance

The stock has a market cap of $6.05 billion, a price-to-earnings ratio of 20.02 and a beta of 1.14. The firm’s 50-day moving average is $9.48 and its two-hundred day moving average is $10.63. The company has a current ratio of 3.33, a quick ratio of 2.44 and a debt-to-equity ratio of 0.12.

Sysmex (OTCMKTS:SSMXY) last announced its quarterly earnings data on Thursday, February 12th. The company reported $0.15 earnings per share for the quarter, beating analysts’ consensus estimates of $0.14 by $0.01. The company had revenue of $837.32 million for the quarter, compared to analyst estimates of $819.99 million. Sysmex had a return on equity of 9.27% and a net margin of 8.86%. As a group, sell-side analysts expect that Sysmex Corporation ADR will post 0.57 earnings per share for the current year.

Sysmex Company Profile

Sysmex Corporation (OTCMKTS: SSMXY) is a Japan‐based provider of in vitro diagnostic solutions, specializing in haematology, coagulation, urinalysis and immunochemistry systems. Headquartered in Kobe, the company designs and manufactures a comprehensive portfolio of automated analyzers, reagents and software to support clinical laboratories, hospitals and research institutions. Sysmex’s product lineup also includes digital pathology platforms and data management tools that integrate workflow automation and advanced analytics.

The company’s core offerings center on haematology analyzers such as the XN-Series, which deliver high‐speed, high‐volume testing for blood cell counts and differential analysis.